Skip to main content

Table 5 Acute toxicity (greater than grade 2) according to the Common Terminology Criteria for Adverse Events version 5.0.

From: The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma

Toxicity

Neoadjuvant RCT n (%)

Other therapies n (%)

 

Grade 3

Grade 4

Grade 3

Grade 4

Hematological

 Anemia

4 (17.4)

0 (0)

9 (9.8)

1 (1.1)

 Leukopenia

3 (13)

3 (13)

2 (2.2)

3 (3.3)

 Lymphocytopenia

7 (30)

1 (4.3)

7 (7.6)

1 (1.1)

 Neutropenia

0 (0)

9 (39.1)

1 (1.1)

6 (6.5)

 Thrombocytopenia

3 (13)

1 (4.3)

1 (1.1)

1 (1.1)

 Overall hematological

12 (52.2%)

(Grade 3 + 4)

17 (18.5%)

(Grade 3 + 4)

Fatigue

3 (13)

0 (0)

4 (4.3)

0 (0)

Gastrointestinal

 Nausea

1 (4.3)

0 (0)

5 (5.4)

0 (0)

 Dysgeusia

0 (0)

0 (0)

1 (1.1)

0 (0)

 Dysphagia

0 (0)

0 (0)

1 (1.1)

0 (0)

Dermatological

 Erythema

0 (0)

0 (0)

3 (3.3)

0 (0)

 Radiodermatitis

2 (8.7)

0 (0)

2 (2.2)

0 (0)

 Hyperpigmentation

0 (0)

0 (0)

3 (3.3)

0 (0)

 Epitheliolysis

0 (0)

0 (0)

2 (2.2)

0 (0)

 Lymphedema

0 (0)

0 (0)

3 (3.3)

0 (0)

Inflammation

 Mucositis

1 (4.3)

0 (0)

1 (1.1)

1 (1.1)

 Stomatitis

2 (8.7)

0 (0)

0 (0)

0 (0)

Neurological

 Psychosis

0 (0)

0 (0)

1 (1.1)

0 (0)

 Wound complication

6 (26.1)

0 (0)

10 (10.9)

5 (5.4)

 Other

1 (4.3)

0 (0)

1 (1.1)

1 (0)

  1. No grade 5 toxicity was observed